A large percentage of patients starting a medication take expensive brand-name products instead of biosimilars, even as health plans and PBMs work on converting existing brand-name prescriptions to ...

In 1989, the Institute of Medicine (IOM) convened a committee on utilization management (UM) to examine the growing role of UM in the US health care system and assess its potential effects on patient ...

Master Medicare Part D: compare plans, review ANOC, and know the 4 stages of coverage to save hundreds on prescription drugs ...

Andrea Iannucci, PharmD, BCOP, assistant chief pharmacist at UC Davis Health, spoke with The American Journal of Managed Care ® (AJMC ®) about the accessibility of new formulary drugs in oncology and ...

After the Veterans Health Administration tweaked its formulary on an asthma and chronic obstructive pulmonary disease therapy, hospitalizations and emergency department visits increased, according to ...

Excellus BlueCross BlueShield is pushing back against reports that it will no longer cover GLP-1 medications, saying drugs used to treat certain medical conditions remain covered. The insurer said GLP ...

Scienture's Arbli, the first ready-to-use liquid losartan, gains formulary access with coverage for over 100 million lives ...